OC
TWST icon

Oarsman Capital’s Twist Bioscience TWST Stock Holding History

Oarsman Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-285
Closed -$13.2K – 797
2024
Q4 		$13.2K Hold
285
– – ﹤0.01% 658
2024
Q3 		$12.9K Buy
+285
New +$13.6K ﹤0.01% 668

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Oarsman Capital's TWST Position: Q1 2025 in Review

Oarsman Capital sold out of Twist Bioscience (TWST) in Q1 2025, closing a stake of 285 shares — an estimated $13.2K sold.

Oarsman Capital first reported a position in TWST in Q3 2024 and held it in 2 quarters. The position peaked at $13.2K in Q4 2024. 262 funds tracked by Wall St. Rank hold TWST as of Q1 2025.

  • Oarsman Capital reported no remaining Twist Bioscience position as of Q1 2025 after selling out during the quarter.
  • Oarsman Capital sold 285 Twist Bioscience shares in Q1 2025, an estimated $13.2K.
  • Oarsman Capital first reported a position in Twist Bioscience in Q3 2024 and held it in 2 quarters.
  • Oarsman Capital's Twist Bioscience position peaked at $13.2K in Q4 2024.
  • 262 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.